Hurel Corp. Names MacDonald to Board

Hurel Corp., a provider of advanced artificial tissue constructs and microfluidic cell-based assay platforms, has named Dr. James S. MacDonald to its board of directors. Hurel recently secured a $9.2 million Series A equity private placement led by Spring Mountain Capital. Hurel is based in both North Brunswick, NJ and Beverly Hills, Calif.

21 May 2013•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles